Frontlight ResearchEarly access
Trial site
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Obesity10 trials
- Type 2 diabetes6 trials
- High blood pressure3 trials
- Type 1 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Completed3 trials
- Lead sponsor
- Eli Lilly and Company7 trials
- Amgen3 trials
- Pfizer2 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity4 recruiting
- Type 2 diabetes2 recruiting
Closed trials
Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026